Financial data tables

Sanofi (SNY) figures from its financial statements (company filings via Financial Modeling Prep), in US dollars; non-US reporters are converted to US dollars. Periods carry the company's own fiscal quarter and year, as its filings name them, with the date each period ended. Source filings are on the Filings tab.

Sanofi quarterly results
PeriodRevenueGross profitOperating incomeNet incomeDiluted EPSGross marginOperating margin
Q3 FY2026 (ended Sep 30, 2026)$16.45B$12.53B$5.08B$3.26B$1.3676.2%30.9%
Q2 FY2026 (ended Jun 30, 2026)$13.28B$10.03B$2.58B$370.0M$0.1575.5%19.4%
Q1 FY2026 (ended Mar 31, 2026)$12.14B$8.75B$2.45B$1.74B$0.7272.1%20.2%
Q4 FY2025 (ended Dec 31, 2025)$13.18B$9.26B-$1.12B-$865.0M-$1.5870.3%-8.5%
Q3 FY2025 (ended Sep 30, 2025)$14.22B$10.54B$3.91B$3.03B$1.2374.1%27.5%
Q2 FY2025 (ended Jun 30, 2025)$11.59B$8.36B$1.59B$4.25B$1.7372.1%13.7%
Q1 FY2025 (ended Mar 31, 2025)$11.45B$8.33B$2.41B$2.02B$0.8272.8%21.1%
Q4 FY2024 (ended Dec 31, 2024)$8.24B$5.79B$619.0M$539.0M$0.3870.2%7.5%
Sanofi quarterly cash flow
PeriodOperating cash flowCapital expendituresFree cash flowShare repurchasesDividends paid
Q3 FY2026 (ended Sep 30, 2026)$4.18B$680.0M$3.50B$19.0M$0.0M
Q2 FY2026 (ended Jun 30, 2026)$5.85B$1.63B$4.22B$1.27B$6.20B
Q1 FY2026 (ended Mar 31, 2026)$1.82B$0.0M$1.82B$0.0M$0.0M
Q4 FY2025 (ended Dec 31, 2025)$3.72B$2.01B$1.71B$0.0M$0.0M
Q3 FY2025 (ended Sep 30, 2025)$4.05B$913.0M$4.96B$31.0M$0.0M
Q2 FY2025 (ended Jun 30, 2025)$0.0M$0.0M$0.0M$0.0M$0.0M
Q1 FY2025 (ended Mar 31, 2025)$2.26B$0.0M$2.26B$0.0M$0.0M
Q4 FY2024 (ended Dec 31, 2024)$0.0M$0.0M$0.0M$0.0M$0.0M
Sanofi balance sheet
PeriodTotal assetsCash and equivalentsShort-term investmentsTotal debtTotal equity
Q3 FY2026 (ended Sep 30, 2026)$140.71B$6.44B$0.0M$21.43B$78.71B
Q2 FY2026 (ended Jun 30, 2026)$139.38B$6.86B$0.0M$25.46B$74.74B
Q1 FY2026 (ended Mar 31, 2026)$138.27B$5.99B$0.0M$21.62B$78.63B
Q4 FY2025 (ended Dec 31, 2025)$136.95B$8.27B$875.0M$21.95B$77.09B
Sanofi employees
YearEmployees
2025300,000
202482,878
202386,088
202291,573
202195,442
202099,412

Sanofi (SNY) reported revenue of $16.45B in Q3 2026.

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites